- Now
- Next
- Later
Future StarLaboratories
We build programmable biological testing platforms for Physical AI laboratories: assays that software can set up, run, measure and analyse. We are starting with bacteria.
- Legal entity
- Future Star Labs LLC
- Based in
- Dallas–Fort Worth
- First product
- BacteSign
Biology is still hard to automate.
- 01The problem
Manual handling
Biological experiments depend on hands-on sample preparation that is slow and hard to standardise.
- 02The problem
Reproducibility
Results shift between operators, runs and labs, so the same test can give different answers.
- 03The problem
Cost and training
Consumables are expensive, and every assay takes skilled staff time to learn and run well.
- 04The problem
Machines are learning the bench
AI-driven robots are learning to pipette, handle samples and run experiments. They need assays built for machines: consistent, measurable and controlled by software. Future Star Laboratories builds its assays that way from the start.
Engineer the assay itself.
Instead of bolting robots onto existing lab equipment, we design the assay so it can be automated from the start. We control where cells sit and what they are exposed to, then connect that to sensing and software.
From bacteria to human cells.
- Now
BacteSign for research use
Bring fluid handling, sensing, instrument control and software together into one system for research-use evaluation.
In development - Next
AI-lab integration and external validation
Connect BacteSign to AI-driven lab automation end to end, and have it tested outside our own lab.
Planned - Later
Mammalian-cell applications
Toxicity and efficacy screening for therapeutics, organoid growth monitoring, and blood-brain barrier models for neurological drug testing. Each needs its own biological validation; bacterial results don't carry over.
Planned
The founders.
- Co-founder · Technical lead
Andre Childs
PhD in Materials Science and Engineering, University of Central Florida (2024). Research in biosensors, microfabricated assays, bacterial identification and antibiotic susceptibility testing. Leads assay engineering, microfabrication, sensor development and prototyping.
- Co-founder · Clinical research
Karolina Budzen
Brings clinical research expertise, identifies the biomedical use cases where better testing matters most, and shapes product development.